Inner Mongolia Furui Med Sci (300049) - Total Liabilities
Based on the latest financial reports, Inner Mongolia Furui Med Sci (300049) has total liabilities worth CN¥652.21 Million CNY (≈ $95.44 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 300049 cash flow metrics to assess how effectively this company generates cash.
Inner Mongolia Furui Med Sci - Total Liabilities Trend (2006–2025)
This chart illustrates how Inner Mongolia Furui Med Sci's total liabilities have evolved over time, based on quarterly financial data. Check Inner Mongolia Furui Med Sci (300049) asset resilience to evaluate the company's liquid asset resilience ratio.
Inner Mongolia Furui Med Sci Competitors by Total Liabilities
The table below lists competitors of Inner Mongolia Furui Med Sci ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Guobang Pharma Ltd
SHG:605507
|
China | CN¥2.30 Billion |
|
OPT Machine Vision Tech Co. Ltd. A
SHG:688686
|
China | CN¥460.29 Million |
|
Shenzhen Topband Co Ltd
SHE:002139
|
China | CN¥6.61 Billion |
|
Coty Inc
NYSE:COTY
|
USA | $7.27 Billion |
|
WHA Corporation Public Company Limited
BK:WHA-R
|
Thailand | ฿60.80 Billion |
|
Nuvoton Technology Corp
TW:4919
|
Taiwan | NT$18.98 Billion |
|
NCC AB (publ)
ST:NCC-B
|
Sweden | Skr25.25 Billion |
|
NOS S.G.P.S. S.A.
LS:NOS
|
Portugal | €2.49 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Inner Mongolia Furui Med Sci's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300049 company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inner Mongolia Furui Med Sci's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inner Mongolia Furui Med Sci (2006–2025)
The table below shows the annual total liabilities of Inner Mongolia Furui Med Sci from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥652.21 Million ≈ $95.44 Million |
-29.94% |
| 2024-12-31 | CN¥930.99 Million ≈ $136.23 Million |
+16.36% |
| 2023-12-31 | CN¥800.09 Million ≈ $117.08 Million |
+14.75% |
| 2022-12-31 | CN¥697.25 Million ≈ $102.03 Million |
-3.02% |
| 2021-12-31 | CN¥718.97 Million ≈ $105.21 Million |
+6.51% |
| 2020-12-31 | CN¥675.02 Million ≈ $98.78 Million |
-3.38% |
| 2019-12-31 | CN¥698.66 Million ≈ $102.24 Million |
+12.24% |
| 2018-12-31 | CN¥622.47 Million ≈ $91.09 Million |
+4.72% |
| 2017-12-31 | CN¥594.42 Million ≈ $86.98 Million |
+2.28% |
| 2016-12-31 | CN¥581.15 Million ≈ $85.04 Million |
+48.87% |
| 2015-12-31 | CN¥390.37 Million ≈ $57.12 Million |
-6.18% |
| 2014-12-31 | CN¥416.10 Million ≈ $60.89 Million |
+5.81% |
| 2013-12-31 | CN¥393.25 Million ≈ $57.54 Million |
+102.76% |
| 2012-12-31 | CN¥193.94 Million ≈ $28.38 Million |
+13.84% |
| 2011-12-31 | CN¥170.37 Million ≈ $24.93 Million |
+57.40% |
| 2010-12-31 | CN¥108.24 Million ≈ $15.84 Million |
+15.76% |
| 2009-12-31 | CN¥93.51 Million ≈ $13.68 Million |
+11.88% |
| 2008-12-31 | CN¥83.58 Million ≈ $12.23 Million |
+14.23% |
| 2007-12-31 | CN¥73.17 Million ≈ $10.71 Million |
+15.60% |
| 2006-12-31 | CN¥63.29 Million ≈ $9.26 Million |
-- |
About Inner Mongolia Furui Med Sci
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules… Read more